Fidelis Capital Partners LLC Has $646,000 Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Fidelis Capital Partners LLC grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 19.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,386 shares of the company’s stock after acquiring an additional 383 shares during the period. Fidelis Capital Partners LLC’s holdings in HCA Healthcare were worth $646,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Stone House Investment Management LLC bought a new position in HCA Healthcare during the third quarter worth $25,000. Centerpoint Advisors LLC acquired a new position in HCA Healthcare in the 4th quarter valued at about $27,000. Bruce G. Allen Investments LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $28,000. Northwest Investment Counselors LLC lifted its holdings in HCA Healthcare by 92.9% during the 3rd quarter. Northwest Investment Counselors LLC now owns 108 shares of the company’s stock worth $27,000 after purchasing an additional 52 shares during the last quarter. Finally, BluePath Capital Management LLC acquired a new position in HCA Healthcare in the 3rd quarter valued at $27,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on HCA shares. Raymond James lifted their price target on shares of HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research report on Wednesday, January 31st. Deutsche Bank Aktiengesellschaft upped their price target on shares of HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a report on Friday, April 12th. Wells Fargo & Company raised their target price on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a report on Thursday, March 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 target price on shares of HCA Healthcare in a research report on Wednesday, April 10th. Finally, StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 15th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $314.05.

HCA Healthcare Stock Up 2.3 %

NYSE:HCA traded up $6.79 on Friday, hitting $303.79. The stock had a trading volume of 362,822 shares, compared to its average volume of 1,071,454. The company has a quick ratio of 1.02, a current ratio of 1.18 and a debt-to-equity ratio of 35.07. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $335.83. The business’s fifty day moving average is $320.06 and its 200 day moving average is $280.94. The company has a market cap of $80.35 billion, a PE ratio of 15.65, a P/E/G ratio of 1.50 and a beta of 1.65.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share for the quarter, topping analysts’ consensus estimates of $5.05 by $0.85. The firm had revenue of $17.30 billion for the quarter, compared to the consensus estimate of $16.51 billion. HCA Healthcare had a return on equity of 996.30% and a net margin of 8.07%. The company’s revenue was up 11.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.64 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 20.58 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were paid a $0.66 dividend. The ex-dividend date of this dividend was Thursday, March 14th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.60. This represents a $2.64 annualized dividend and a yield of 0.87%. HCA Healthcare’s dividend payout ratio is currently 13.91%.

HCA Healthcare declared that its Board of Directors has authorized a share buyback plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 7.4% of its stock through open market purchases. Stock buyback plans are usually an indication that the company’s leadership believes its shares are undervalued.

Insider Activity

In other HCA Healthcare news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total value of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, SVP Chad J. Wasserman sold 876 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the transaction, the senior vice president now directly owns 1,576 shares of the company’s stock, valued at $520,474. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Chad J. Wasserman sold 344 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total transaction of $110,757.68. Following the completion of the transaction, the senior vice president now owns 2,452 shares in the company, valued at approximately $789,470.44. The disclosure for this sale can be found here. Insiders sold 14,840 shares of company stock worth $4,588,869 in the last three months. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.